Nadim Ahmed - Jun 28, 2023 Form 4 Insider Report for Cullinan Oncology, Inc. (CGEM)

Role
President and CEO, Director
Signature
/s/ Jacquelyn Sumer, Attorney-in-Fact
Stock symbol
CGEM
Transactions as of
Jun 28, 2023
Transactions value $
-$8,653
Form type
4
Date filed
6/29/2023, 04:59 PM
Previous filing
May 24, 2023
Next filing
Dec 27, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CGEM Common Stock Sale -$8.65K -759 -0.65% $11.40 116K Jun 28, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.